H.C. Wainwright Maintains Buy on Ocular Therapeutix, Lowers Price Target to $6

H.C. Wainwright maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and lowers the price target from $9 to $6.

Benzinga · 11/15/2019 12:31

H.C. Wainwright maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and lowers the price target from $9 to $6.